Pranitha Naini, MD
Medical Oncology · Lansdowne, VANPI 1003959974
Payments from drug & device makers
Across 194 payments — averaging $38.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$2K
- Novartis$1K
- Sanofi$903
- Johnson & Johnson$666
- AstraZeneca$423
- Merck$213
- plus $2K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 21 | $1,982 |
| Novartis | 38 | $1,027 |
| Sanofi | 4 | $903 |
| Johnson & Johnson(2 entities) | 18 | $666 |
| AstraZeneca(2 entities) | 17 | $423 |
| Merck | 9 | $213 |
| AbbVie | 7 | $195 |
| E.r. Squibb & Sons, L.L.C. | 7 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $159 |
| Gilead | 6 | $150 |
| Rigel Pharmaceuticals, Inc. | 2 | $144 |
| Caris MPI, Inc. | 6 | $125 |
| Karyopharm Therapeutics Inc. | 1 | $116 |
| Eisai Inc. | 5 | $115 |
| Genmab U.S., Inc. | 3 | $98 |
| Genentech USA, Inc. | 4 | $96 |
| Sobi, Inc | 4 | $88 |
| Tersera Therapeutics LLC | 3 | $83 |
| Beone Medicines USA, Inc. | 3 | $76 |
| Pfizer | 3 | $76 |
| Lilly USA, LLC | 3 | $67 |
| Myriad Genetic Laboratories, Inc. | 3 | $65 |
| Pharmaessentia USA Corporation | 2 | $65 |
| GSK | 2 | $51 |
| Exelixis Inc. | 2 | $50 |
| Adaptive Biotechnologies Corporation | 2 | $49 |
| Array Biopharma Inc | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $29 |
| Invivyd Inc | 1 | $28 |
| Beigene USA, Inc. | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Acrotech Biopharma Inc. | 1 | $18 |
| Bayer | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
How this compares
$7,530 in reported general payments places this provider in the 45th percentile of 95 medical oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Lansdowne
- Rangappa RajendraLansdowne$6K
- Alexander SpiraFairfax$69.5M
- Jeanny Aragon-ChingFalls Church$9.4M
- Ryan GentzlerCharlottesville$5.6M
- Robert DreicerCharlottesville$5.4M
- Kathleen HarndenFairfax$4M
- Matthew ReilleyCharlottesville$3.8M
- Patrick DillonCharlottesville$2.6M
- Varinder KaurCharlottesville$2.4M
- Adam CohenFairfax$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.